Statins for Clonal Cytopenia and Myelodysplastic Syndromes
Phase 2
16
about 3.3 years
18+
1 site in MO
Why this study is shown
What this study is about
This trial is testing whether statins can help people with clonal cytopenia of undetermined significance (CCUS) and lower-risk myelodysplastic syndromes (MDS). The goal is to see if taking a statin at the time of diagnosis will reduce inflammation and slow down the progression of these conditions.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Atorvastatin
- 2.Take Rosuvastatin
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
atorvastatin (Statin; inhibits HMG-CoA reductase to lower cholesterol), rosuvastatin
oral, oral (Oral Capsule)